We are live on
!
Find out more
FI
Fosun International Portfolio holdings
AUM
$399M
1-Year Est. Return
16.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.65%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.51B
AUM Growth
-$59.4M
(-3.8%)
Cap. Flow
+$92.2M
Cap. Flow
% of AUM
6.09%
Top 10 Holdings %
Top 10 Hldgs %
50.09%
Holding
339
New
32
Increased
81
Reduced
57
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CIH
China Index Holdings Limited American Depository Shares
CIH
|
+$10.8M |
| 2 |
AbbVie
ABBV
|
+$7.55M |
| 3 |
QTT
Qutoutiao Inc. American Depositary Shares
QTT
|
+$4.66M |
| 4 |
Agios Pharmaceuticals
AGIO
|
+$3.3M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
+$3.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BZUN
Baozun
BZUN
|
+$20.3M |
| 2 |
DigitalBridge
DBRG
|
+$14.9M |
| 3 |
Brookdale Senior Living
BKD
|
+$12.7M |
| 4 |
Vipshop
VIPS
|
+$8.37M |
| 5 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
+$6.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.82% |
| 2 | Financials | 5.48% |
| 3 | Industrials | 3.38% |
| 4 | Technology | 2.61% |
| 5 | Communication Services | 2.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRAY
1
DELISTED
ViewRay, Inc.
VRAY
| $145M | 9.58% |
16,470,258
-1,000
| -0% | -$8.12K |
|
2
Amneal Pharmaceuticals
AMRX
$5.59B
| $140M | 9.25% |
19,552,001
| – | – |
|
|
SINA
3
DELISTED
Sina Corp
SINA
| $84.5M | 5.58% |
1,960,066
-7,512
| -0.4% | -$394K |
|
|
BEST
4
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $38M | 2.51% |
345,046
+13,345
| +4% | +$1.38M |
|
|
5
DigitalBridge
DBRG
$2.92B
| $33.8M | 2.23% |
1,692,324
-718,137
| -30% | -$14.9M |
|
6
Gilead Sciences
GILD
$165B
| $27.3M | 1.8% |
404,973
+8,530
| +2% | +$561K |
|
7
Nature's Sunshine
NATR
$369M
| $26.5M | 1.75% |
2,854,607
| – | – |
|
|
ARRY
8
DELISTED
Array Biopharma Inc
ARRY
| $23.1M | 1.52% |
498,733
+114,678
| +30% | +$3.22M |
|
|
SOHU
9
Sohu.com
SOHU
$346M
| $15.1M | 0.99% |
1,075,995
| – | – |
|
|
CIH
10
DELISTED
China Index Holdings Limited American Depository Shares
CIH
| $11.3M | 0.75% |
+3,186,499
| New | +$10.8M |
|
11
Incyte
INCY
$23.1B
| $10.1M | 0.67% |
119,310
+34,500
| +41% | +$2.77M |
|
|
SFUN
12
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $10.1M | 0.66% |
323,617
| – | – |
|
13
Neurocrine Biosciences
NBIX
$17.4B
| $9.75M | 0.64% |
118,323
+17,000
| +17% | +$1.4M |
|
|
14
Brookdale Senior Living
BKD
$3.57B
| $9.54M | 0.63% |
1,323,000
-1,929,078
| -59% | -$12.7M |
|
15
Iovance Biotherapeutics
IOVA
$2.24B
| $9.33M | 0.62% |
413,154
| – | – |
|
16
Verrica Pharmaceuticals
VRCA
$94.3M
| $9.23M | 0.61% |
79,428
| – | – |
|
|
SGEN
17
DELISTED
Seagen Inc. Common Stock
SGEN
| $8.92M | 0.59% |
132,605
+11,000
| +9% | +$770K |
|
|
FOLD
18
DELISTED
Amicus Therapeutics
FOLD
| $8.9M | 0.59% |
741,969
+160,000
| +27% | +$2.03M |
|
19
argenx
ARGX
$52.9B
| $8.47M | 0.56% |
61,483
+7,778
| +14% | +$987K |
|
20
BioMarin Pharmaceuticals
BMRN
$11.4B
| $8.21M | 0.54% |
97,650
| – | – |
|
21
Ascendis Pharma A/S
ASND
$16.5B
| $8.1M | 0.53% |
74,689
+7,263
| +11% | +$869K |
|
22
Kura Oncology
KURA
$948M
| $7.34M | 0.48% |
370,958
+65,000
| +21% | +$1.08M |
|
23
Brookfield Renewable
BEP
$9.72B
| $7.11M | 0.47% |
225,180
+37,530
| +20% | +$648K |
|
|
24
AbbVie
ABBV
$448B
| $6.72M | 0.44% |
+96,000
| New | +$7.55M |
|
25
Deutsche Bank
DB
$66.4B
| $6.43M | 0.42% |
861,000
+68,000
| +9% | +$524K |
|
Similar funds
NC
T2I
BA
IAA
PNFS
THL
LWPC
MHC
Fosun International's Q2 2019 Portfolio in Review
As of Q2 2019, Fosun International held 339 positions worth $1.51B, down 3.8% from $1.57B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Fosun International deployed $92.2M of net new capital in Q2 2019, opening 32 new positions and adding to 81 existing holdings. Its largest new stake was China Index Holdings Limited American Depository Shares: 3,186,499 shares worth $11.3M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was DigitalBridge, an estimated $14.9M trimmed.
- Fosun International's largest Q2 2019 buy was China Index Holdings Limited American Depository Shares: 3,186,499 shares worth $11.3M.
- Fosun International added most to Array Biopharma Inc in Q2 2019, an estimated $3.22M increase.
- Fosun International's biggest Q2 2019 reduction was DigitalBridge, cutting an estimated $14.9M.
- Fosun International fully exited Baozun in Q2 2019, selling an estimated $20.3M.
- Fosun International's ten largest holdings make up 50% of its $1.51B portfolio in Q2 2019.
- Fosun International opened 32 new positions and closed 39 in Q2 2019.
- Fosun International's portfolio value fell 3.8% quarter-over-quarter to $1.51B.
Based on Fosun International's 13F filing for Q2 2019, filed 12 Aug 2019.